Articles On Sigma Healthcare (ASX:SIG)

At the time of writing, the ASX 200 Health Index (XHJ) is down 2%, while the benchmark ASX 200 is also falling by 0.75%. The path is now open for pharma distributor Australian Pharmaceutical Industries (ASX: API) to be acquired by Wesfarmer...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

The Wesfarmers Ltd (ASX: WES) share price performed well through 2021. After ending 2020 trading at $50.40, the company’s share price rose to close 2021 at $59.30. That means the retail conglomerate gained 17.66% last year, recording a hig...

It’s been a wild rise for market watchers interested in Wesfarmers Ltd‘s (ASX: WES) takeover of Australian Pharmaceuticals Industries Ltd (ASX: API). The company’s bid has been blindsided twice, once by Sigma Healthcare Ltd (ASX: SIG) and...

Woolworths Group Ltd (ASX: WOW) today announced it has withdrawn its non-binding proposal for Priceline owner Australian Pharmaceutical Industries Ltd (ASX: API). Subsequently, the API share price has tumbled 12.43% in morning trade to $1.5...

Paragon Care (PGC) has appointed Mark Hooper as group chief executive officer (CEO) and managing director of the company Mark Hooper is the current CEO of Sigma Healthcare, announcing his tendered resignation after almost 11 years Over the...

The Sigma Healthcare Ltd (ASX: SIG) share price has had a disappointing month, falling by more than 14% so far. This comes after the pharmacy chain operator and distributor provided investors with a trading update earlier in December. At t...

What a year it’s been for the Australian healthcare sector in 2021. It has had to come to grips with the lasting effects of COVID-19, and has experienced a wave of disruption and innovation at levels not seen before. Meanwhile, surging cas...

ShareCafeThe Week that Was – December 6-10, 2021 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do so...

World Overnight SPI Overnight 7368.00 – 10.00 – 0.14% S&P ASX 200 7384.50 – 20.90 – 0.28% S&P500 4667.45 – 33.76 – 0.72% Nasdaq Comp 15517.37 – 269.62 – 1.71% DJIA 35754.69 – 0.06 – 0.00% S&P500 VIX 21.58 + 1.68 8....

ShareCafeEBOS Goes to Market to Fund Expansion NZ healthcare and pet food group EBOS seems to have ruled itself out of any role in the restructuring of the highly protected Australian pharmacy sector that emerged in late November when Woolw...

In late trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 1.5% to 7,426 points. Four ASX shares that have failed to follow the market higher today are listed...

World Overnight SPI Overnight 7376.00 + 22.00 0.30% S&P ASX 200 7313.90 + 68.80 0.95% S&P500 4686.75 + 95.08 2.07% Nasdaq Comp 15686.92 + 461.76 3.03% DJIA 35719.43 + 492.40 1.40% S&P500 VIX 21.89 – 5.29 – 19.46%...

ShareCafeSIG – Citi rates the stock as Neutral Following a trading update by Sigma Healthcare, Citi reduces FY22-24 EPS forecasts by -24%, -15% and -2%, respectively and lowers its target price to $0.50 from $0.60. The Neutral rating is unc...

The S&P/ASX 200 Index (ASX: XJO) has followed the lead of Wall Street and is on track to record a strong gain. In afternoon trade, the benchmark index is up 1% to 7,320.5 points. Four ASX shares that have failed to follow the market hi...

The S&P/ASX 200 (ASX: XJO) managed to eke out a tiny gain of just 4 points on Monday, overcoming a mixed overseas lead. ASX BNPL rout sinks market This was despite significant selling pressure facing the technology sector, but more spec...

ShareCafeMarket Murmurs: SIG, BLD It’s been a ‘big’ five weeks or so for Sigma Healthcare and a 52-week low for the shares yesterday capped off what has turned out to be a boom-and-bust period. Just over a month ago, Sigma was briefly a wan...

The share market finished modestly higher as traders dumped speculative and growth stocks in favour of defensive sectors. The S&P/ASX 200 edged up four points or 0.05 per cent to record back-to-back gains for the first time since the...

The Sigma Healthcare Ltd (ASX: SIG) share price has sunk into the red today after the business downgraded profit expectations. Subsequently, the Sigma share price is down 6.67% to $0.49. SIG share price Source: Rask Media SIG 1-year share p...

Highlights Metcash shares topped the ASX gainers’ chart as investors cheered its earnings report. Boral shares surged after it signed a deal to sell its North American fly ash business. Shares of Bapcor declined 9% on the sudden exit...

Highlights The ASX 200 dropped 0.2% by the mid-session on Monday. Six of the 11 sectors traded in green, while tech and health care declined the most. Zip Co, Nearmap, Redbubble, Bapcor, Kogan.com topped the ASX losers’ chart. On Fri...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decline. At the time of writing, the benchmark index is down 0.4% to 7,213.2 points. Four ASX shares that are falling more than most today are l...

The Sigma Healthcare Ltd (ASX: SIG) share price is plunging today after the company predicted its earnings will fall this financial year. The Sigma share price is currently down by 6.67%, trading hands at 49 cents a piece. This is a 52-w...

06 Dec 2021 - Sigma Healthcare (ASX:SIG) has cut its earnings guidance for the 2022 financial year (ending January 2022), saying it now expects underlying EBITDA to be down around …

Aussie shares gave up tentative early gains as the tech sector fell to a five-month low and the major miners weakened. The S&P/ASX 200 reached mid-session 25 points or 0.34 per cent in the red. The Australian benchmark edged up 11 po...

Highlights The Australian share market opened flat after treasurer Josh Frydenberg’s comments. At 11 AM (AEST), the ASX 200 was trading at 7,237.10, down 0.057%. While the ASX All Ordinaries index was down 0.025% or 10 points to 7,543...

ASX seesaws at the open after weak US market; Afterpay falls as vote delayed to Dec 14.  Sigma Healthcare downgrades earnings, Boral to sell US asset for $1bn, Metcash profits soar and Bapcor removes Abotomey as CEO.

Competition between Wesfarmers Ltd (ASX: WES) and Woolworths Group Ltd (ASX: WOW) has burst into an inferno as the pair go head to head to take over the owner of Priceline. The latter retail giant lobbed a bid for Australian Pharmaceutical...

ShareCafeWoolworths Gatecrashes API Party Shares in Australian Pharmaceutical Industries (ASX: API) soared more than 16% on Thursday to a high of $1.74 after Woolworths (ASX: WOW) crashed Wesfarmers’ attempt to take control of the company....

The Australian Pharmaceuticals Industries (ASX:API) takeover saga took another twist today with Woolworths (ASX:WOW) making a late bid. API (which runs Priceline Pharmacy and Clear Skincare clinics among other brands) has been a target sinc...

The Wesfarmers Ltd (ASX: WES) and Woolworths Group Ltd (ASX: WOW) rivalry has been reignited today after Woolworths lobbed a $1.75 per share offer for Australian Pharmaceutical Industries Ltd (ASX: API). Previously, Wesfarmers had made a bi...

ShareCafeTakeover Talk: SYD, SXY, API Three deals advanced to the closing rounds of their respective games yesterday. ………… Sydney Airport (ASX: SYD) has agreed to a $32 billion takeover bid by a consortium led by the superannuation fund-bac...

The Australian Pharmaceutical Industries Ltd (ASX: API) share price has moved higher today after the pharmacy distributor entered into a Scheme of Implementation Deed with Wesfarmers Ltd (ASX: WES). The API share price is up 2.69% to $1.52....

The Wesfarmers Ltd (ASX: WES) share price rose by 2% today as it seemed that it’s in prime position to take over Australian Pharmaceutical Industries Ltd (ASX: API). What happened today? The other contender for API has been Sigma Healthcare...

Sigma Healthcare (SIG) walks away from Australian Pharmaceutical Industries (API) merger The company will leave the battle for the Australian pharmaceutical chain after Wesfarmers (WES) increased its stake in API to nearly 20 per cent Eve...

The Wesfarmers Ltd (ASX: WES) share price finished in the green today amid news a rival bidder for Australian Pharmaceutical Industries Ltd (ASX: API) has backed down. Sigma Healthcare Ltd (ASX: SIG) withdrew its takeover proposition for t...

Australian shares ended the week at their highest since mid-September after the Reserve Bank reaffirmed it foresees no rate rises next year. The S&P/ASX 200 rallied 29 points or 0.4 per cent to 7457. The index last closed higher midw...

The Sigma Healthcare Ltd (ASX: SIG) share price is pushing higher on Friday. This comes after the company provided an update on the current proposal to merge with Australian Pharmaceutical Industries Ltd (ASX: API). At the time of writing,...

Sigma Healthcare has conceded defeat in its fight for control of the Priceline Pharmacy owner, paving the way for Wesfarmers to make its first foray into the lucrative healthcare sector.

Sigma Healthcare (ASX: SIG) has bowed out of the race to acquire Priceline Pharmacy owner Australian Pharmaceutical Industries (ASX: API), leaving an open field to competing suitor Wesfarmers (ASX: WES). In late September Sigma marginally...

The S&P/ASX 200 Index (ASX: XJO) shares in this article might be good considerations to think about today. Businesses in the ASX 200 are often among the biggest and strongest in their industry. The two investments below are ones that m...

As it turns out, the Australian share market didn’t exactly have a fantastic month over October. The S&P/ASX 200 Index (ASX: XJO) ended up losing roughly 0.1% over the month that was. Yawn. But one ASX 200 blue chip share managed a far...

Some time has passed since the first Wesfarmers Ltd (ASX: WES) bid for Australian Pharmaceutical Industries Ltd (ASX: API). What’s going on? API recently announced its FY21 result for the 12 months to 31 August 2021. The business gave an u...

The Wesfarmers Ltd (ASX: WES) share price is having a month to forget. At the time of writing, shares in the retail conglomerate are trading for $54.95 – up 0.33%. Over the month, however, it’s been less cheery for the company – down 3.48%...

The Wesfarmers Ltd (ASX: WES) share price is in the red on Tuesday. This follows a new development in the tussle for the right to buy Priceline Pharmacy owner Australian Pharmaceutical Industries Ltd (ASX: API). At the time of writing, sha...

ShareCafeAPI Primps and Preens for Suitors Takeover target Australian Pharmaceutical Industries is making sure both its putative bidders understand how it is well it is performing at the moment with a surprise earnings upgrade ahead of the...

There’s a fresh twist in the battle for Priceline Pharmacy owner Australian Pharmaceutical Industries. 

The Wesfarmers Ltd (ASX: WES) share price struggled today amid the latest news about the ongoing takeover fight for Australian Pharmaceutical Industries Ltd (ASX: API). What’s going on? The Wesfarmers share price went down more than 1% tod...

Australian shares declined for the first time in three sessions as surging energy prices helped drive the dollar and long-term interest rates higher. The S&P/ASX 200 fell as much as 70 points before more than halving its loss to 20 p...